Evolent Health, Inc. (EVH)

Market Cap	1.20B
Revenue (ttm)	2.55B
Net Income (ttm)	-93.45M
Shares Out	115.04M
EPS (ttm)	-0.81
PE Ratio	n/a
Forward PE	23.73
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,302,474
Open	10.69
Previous Close	10.71
Day's Range	10.34 - 11.03
52-Week Range	9.45 - 35.00
Beta	1.45
Analysts	Strong Buy
Price Target	16.79 (+60.98%)
Earnings Date	Feb 20, 2025

About EVH

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care wor...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Jun 5, 2015
• Employees: 4,700
• Stock Exchange: NYSE
• Ticker Symbol: EVH
• Website: https://www.evolent.com

Financial Performance

In 2024, Evolent Health's revenue was $2.55 billion, an increase of 30.09% compared to the previous year's $1.96 billion. Losses were -$93.45 million, -34.31% less than in 2023.

Analyst Forecast

According to 14 analysts, the average rating for EVH stock is "Strong Buy." The 12-month stock price forecast is $16.79, which is an increase of 60.98% from the latest price.

Price Target

$16.79

(60.98% upside)

Analyst Consensus: Strong Buy